• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acadia Healthcare Announces Retirement of Chief Executive Officer

    10/5/21 8:30:00 AM ET
    $ACHC
    Medical Specialities
    Health Care
    Get the next $ACHC alert in real time by email

    The Board of Directors of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that Debbie Osteen will retire as CEO. Ms. Osteen will continue to serve on Acadia's Board of Directors and will assist in the selection and transition of the new CEO. It is anticipated that Ms. Osteen's retirement will be effective on January 31, 2022.

    Reeve Waud, Chairman of Acadia's Board of Directors, said, "Debbie has done an outstanding job as Acadia's CEO with the support of a strong senior team, and the Board could not be more pleased with the Company's progress under Debbie's leadership. We are very appreciative of her efforts in leading the Company through a period of significant progress and evolution, with the Company now well-positioned for future growth. Since Debbie joined Acadia in December 2018, she has led Acadia's strategic vision and executed a growth plan that includes the acquisition of 14 facilities, the establishment of nine joint ventures with leading healthcare systems and the expansion of multiple facilities with over 1,000 bed additions. The Company also successfully divested its U.K. business operations, a key strategic priority to focus the Company on growing and expanding its U.S. operations. During her tenure, Acadia's stock price has increased approximately 125%, generating an increase in value to our stockholders of approximately $3.3 billion."

    Ms. Osteen, a 35+ year veteran of the behavioral health care industry, said, "I am proud of what we have accomplished since I joined Acadia. The past three years have provided me with a unique opportunity to work closely with the Board of Directors and leverage my experience in behavioral health to lead Acadia through a critical period. Most importantly, I am proud of the team at Acadia and all our employees who demonstrate their commitment every day by helping the many people who need quality behavioral health care. Our employees' resilience and passion has been particularly evident during the COVID-19 crisis. Despite the unprecedented challenges, we continue to provide care to patients within the communities we serve and fulfill our vital, life-saving mission. Today, with our deep and talented leadership team and over 20,000 dedicated employees, Acadia is well positioned to continue implementing and executing our strategy and growth pathways, solidifying our position as the largest stand-alone behavioral healthcare company in the U.S."

    Mr. Waud remarked, "We thank Debbie for her leadership and the Board is very excited about the next phase in the Company's growth. In addition, the Board appreciates Debbie's desire to ensure a smooth transition of leadership, and to continue to provide her valuable insights by remaining on the Board. The Board has engaged a national recruiting firm to conduct a comprehensive search to identify the right person to lead Acadia in 2022 and beyond. Acadia's new CEO, working with our outstanding leadership team, will continue to execute our strategic growth plan and ensure that Acadia remains a patient-first organization focused on quality of care and an employer of choice delivering strong returns for our stockholders over the long term."

    About Acadia

    Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2021, Acadia operated a network of 229 behavioral healthcare facilities with approximately 10,100 beds in 40 states and Puerto Rico. With more than 20,000 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211005005247/en/

    Get the next $ACHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHC

    DatePrice TargetRatingAnalyst
    1/22/2026$15.00Buy → Hold
    Jefferies
    12/3/2025$14.00Outperform → Market Perform
    Leerink Partners
    12/3/2025$13.00Neutral → Underperform
    BofA Securities
    9/10/2025$25.00Buy → Neutral
    BofA Securities
    8/14/2025$26.00Strong Buy → Outperform
    Raymond James
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $ACHC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer

    Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D

    1/20/26 8:00:00 AM ET
    $ACHC
    $UHS
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, January 12-15, 2026, in San Francisco, California. In connection with the conference, there will be an online webcast of the Company's presentation available on the Company's website starting at 5:15 p.m. Pacific Time/ 7:15 p.m. Central Time on Tuesday, January 13, 2026. The live webcast of the presentation will be available on the Company's website, www.acadiahealthcare.com, by clicking on the "Investors" link. A replay of the presentation will also be available on the Company's website for 30 days. About Acadia Acadia is a leading pr

    1/6/26 11:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance

    Adjusted EBITDA Guidance Reduced by $49M and EPS by $0.41, Driven Entirely by an Increase in Professional and General Liability Expenses Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced an update to its professional and general liability ("PLGL") reserves, following its annual, third-party actuarial review of anticipated PLGL costs. This update reflects higher expected expenses associated primarily with patient-related litigation. As a result, the Company now expects full-year 2025 Adjusted EBITDA in the range of $601 million to $611 million, compared to its prior guidance of $650 million to $660 million, reflecting an incremental $49 million of PL

    12/2/25 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Executive Officer Osteen Debra K

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    1/21/26 4:34:50 PM ET
    $ACHC
    Medical Specialities
    Health Care

    New insider Osteen Debra K claimed ownership of 3,765 shares (SEC Form 3)

    3 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    1/21/26 4:30:29 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Chief Financial Officer Young Todd S. was granted 48,445 shares (SEC Form 4)

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    10/28/25 5:42:07 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Acadia Healthcare downgraded by Jefferies with a new price target

    Jefferies downgraded Acadia Healthcare from Buy to Hold and set a new price target of $15.00

    1/22/26 8:24:52 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Acadia Healthcare from Outperform to Market Perform and set a new price target of $14.00

    12/3/25 8:27:09 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by BofA Securities with a new price target

    BofA Securities downgraded Acadia Healthcare from Neutral to Underperform and set a new price target of $13.00

    12/3/25 8:27:09 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    SEC Filings

    View All

    SEC Form 8-K filed by Acadia Healthcare Company Inc.

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    1/23/26 8:00:15 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Company Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    1/20/26 8:06:57 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    1/13/26 8:00:13 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Leadership Updates

    Live Leadership Updates

    View All

    Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer

    Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D

    1/20/26 8:00:00 AM ET
    $ACHC
    $UHS
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    Acadia Healthcare Appoints Todd Young as Chief Financial Officer

    Young Brings 25 Years of Financial and Healthcare Industry Experience Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company") today announced the appointment of Todd Young as Chief Financial Officer, effective October 27, 2025. Tim Sides, who has been serving as the Company's interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance. Young brings to Acadia nearly a decade of executive-level finance experience at publicly traded healthcare companies. He most recently served as CFO at Elanco Animal Health ("Elanco") where he joined in 2018 as Elanco was separating from Eli Lilly and Company. Young developed a robust finance organiza

    10/7/25 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    $ACHC
    Financials

    Live finance-specific insights

    View All

    Acadia Healthcare Reports Third Quarter 2025 Results

    Third Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year Lowering Full-Year Outlook Acadia Taking Decisive Actions to Optimize Portfolio in Order to Reduce Capital Expenditures and Increase Free Cash Flow Generation Referral Initiatives Drive Accelerating Admissions Growth Todd Young joined as CFO on October 27; Announces departure of COO Dr. Nasser Khan Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Results Revenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024 Same facility revenue increased 3.7% compared with th

    11/5/25 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for Third Quarter 2025 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its third quarter 2025 results on Wednesday, November 5, 2025, after the close of the market. Acadia will conduct a conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, November 6, 2025. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of June 30, 2025, Acadia operated a network of 274 behavioral healthcare facilit

    10/20/25 4:22:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Reports Second Quarter 2025 Results

    Provides Updated Guidance for 2025; Announces Chief Financial Officer Transition Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenue totaled $869.2 million, an increase of 9.2% over the second quarter of 2024 Same facility revenue increased 9.5% compared with the second quarter of 2024, including an increase in revenue per patient day of 7.5% and an increase in patient days of 1.8% Net income attributable to Acadia totaled $30.1 million, or $0.33 per diluted share Adjusted income attributable to Acadia totaled $74.8 million, or $0.83 per

    8/5/25 4:05:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/14/24 1:28:32 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/12/24 9:50:14 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/8/24 10:52:39 AM ET
    $ACHC
    Medical Specialities
    Health Care